Literature DB >> 10051246

Peripheral muscle weakness and exercise capacity in children with cystic fibrosis.

K de Meer1, V A Gulmans, J van Der Laag.   

Abstract

Exercise intolerance in cystic fibrosis (CF) is attributed to diminished nutritional and pulmonary function. We studied the pathophysiology of such intolerance in relation to muscle force and fat-free mass (FFM), in 15 children with moderately severe symptoms of CF (FEV1 < 80% predicted and/or weight for age < -1 SD of reference median), 13 children with mild symptoms of CF (FEV1 and weight above these thresholds), and 13 healthy controls. Cycle maximal workload (Wmax) and V O2max were assessed. Maximal peripheral muscle force was measured, and FFM was calculated from skinfolds. Patients with mild CF, as compared with matched controls, had lower values of Wmax per kilogram of FFM (3.9 +/- 0.5 versus 4.6 +/- 0.3 W/kg [mean +/- SD], respectively; difference = 0.7 [95% CI = 0.4 to 1.1]), and diminished maximal muscle force (2.7 +/- 0.4 kN versus 3.1 +/- 0.7 kN; difference = 0.44 [95% CI = 0.03 to 0.87]), but similar V O2max. Patients with moderate CF had lower FFM, muscle force, and exercise tolerance than did the other groups. Oxygen cost of work was elevated in both groups of CF patients. Muscle force showed a strong positive correlation with Wmax in patients and controls, with disproportionately lower regression slopes in the CF patients. In children with CF, muscle force is decreased and associated with diminished maximal work load, even in the absence of diminished pulmonary or nutritional status.

Entities:  

Mesh:

Year:  1999        PMID: 10051246     DOI: 10.1164/ajrccm.159.3.9802112

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN: 1073-449X            Impact factor:   21.405


  20 in total

1.  Rebuttal from Paula Rodriguez-Miguelez, Melissa L. Erickson, Kevin K. McCully and Ryan A. Harris.

Authors:  Paula Rodriguez-Miguelez; Melissa L Erickson; Kevin K McCully; Ryan A Harris
Journal:  J Physiol       Date:  2017-03-01       Impact factor: 5.182

2.  CrossTalk opposing view: Skeletal muscle oxidative capacity is not altered in cystic fibrosis patients.

Authors:  H J Erik Hulzebos; Jeroen A L Jeneson; Cornelis K van der Ent; Tim Takken
Journal:  J Physiol       Date:  2017-03-01       Impact factor: 5.182

3.  Physical activity recommendations for children with specific chronic health conditions: Juvenile idiopathic arthritis, hemophilia, asthma and cystic fibrosis.

Authors:  J Philpott; K Houghton; A Luke
Journal:  Paediatr Child Health       Date:  2010-04       Impact factor: 2.253

4.  Preferential reduction of quadriceps over respiratory muscle strength and bulk after lung transplantation for cystic fibrosis.

Authors:  C Pinet; P Scillia; M Cassart; M Lamotte; C Knoop; C Mélot; M Estenne
Journal:  Thorax       Date:  2004-09       Impact factor: 9.139

5.  Exercise training in children and adolescents with cystic fibrosis: theory into practice.

Authors:  Craig A Williams; Christian Benden; Daniel Stevens; Thomas Radtke
Journal:  Int J Pediatr       Date:  2010-09-19

6.  Reduced exercise capacity in non-cystic fibrosis bronchiectasis.

Authors:  Soumya Swaminathan; K V Kuppurao; N Somu; V K Vijayan
Journal:  Indian J Pediatr       Date:  2003-07       Impact factor: 1.967

Review 7.  Growth hormone and exercise tolerance in patients with cystic fibrosis.

Authors:  Matthias Hütler; Ralph Beneke
Journal:  Sports Med       Date:  2004       Impact factor: 11.136

Review 8.  Exercise testing and training with the young cystic fibrosis patient.

Authors:  Daniel Stevens; Craig A Williams
Journal:  J Sports Sci Med       Date:  2007-09-01       Impact factor: 2.988

9.  Lack of CFTR in skeletal muscle predisposes to muscle wasting and diaphragm muscle pump failure in cystic fibrosis mice.

Authors:  Maziar Divangahi; Haouaria Balghi; Gawiyou Danialou; Alain S Comtois; Alexandre Demoule; Sheila Ernest; Christina Haston; Renaud Robert; John W Hanrahan; Danuta Radzioch; Basil J Petrof
Journal:  PLoS Genet       Date:  2009-07-31       Impact factor: 5.917

Review 10.  Infection, inflammation and exercise in cystic fibrosis.

Authors:  Pauline Barbera van de Weert-van Leeuwen; Hubertus Gerardus Maria Arets; Cornelis Korstiaan van der Ent; Jeffrey Matthijn Beekman
Journal:  Respir Res       Date:  2013-03-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.